MarketWatch)The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse. There are optics suggesting that we are in a biotech bubble, wrote Ravi Mehrotra at Credit Suisse in a note to investors on Friday.
invite response
http://www.marketwatch.com/story/biotech-bubble-may-just-be-an-optical-illusion-2015-03-27?siteid=yhoof2
#bubbles